Compounds > arsenic
Page last updated: 2024-08-26

arsenic and tanespimycin

arsenic has been researched along with tanespimycin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Carew, JS; Huang, P; Keating, MJ; McQueen, TJ; Pelicano, H; Plunkett, W1
Brady, MT; Earp, JC; Jusko, WJ; Keng, MK; Wetzler, M1
Colombo, M; Mann, KK; Miller, WH1
Allegood, J; Cruickshanks, N; Curiel, DT; Dash, R; Dent, P; Dmitriev, IP; Fisher, PB; Grant, S; Hamed, HA; Mitchell, C; Ogretmen, B; Park, MA; Spiegel, S; Tye, G; Yacoub, A1

Other Studies

4 other study(ies) available for arsenic and tanespimycin

ArticleYear
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
    Leukemia, 2006, Volume: 20, Issue:4

    Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzoquinones; Cytarabine; DNA; Drug Administration Schedule; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; G1 Phase; HeLa Cells; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Oxides; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured

2006
Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Apr-01, Volume: 13, Issue:7

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzoquinones; Cell Line, Tumor; Cell Survival; Drug Synergism; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Models, Theoretical; Oxides; STAT3 Transcription Factor

2007
Arsenic trioxide decreases AKT protein in a caspase-dependent manner.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Arsenic Trioxide; Arsenicals; Benzoquinones; Caspase 3; Caspases; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Lactams, Macrocyclic; Oxides; Proteasome Endopeptidase Complex; Protein Binding; Proto-Oncogene Proteins c-akt

2008
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
    Molecular pharmacology, 2011, Volume: 79, Issue:3

    Topics: Adenoviridae; Animals; Arsenic Trioxide; Arsenicals; Benzoquinones; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Ceramides; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Flow Cytometry; Humans; Interleukins; Kidney Neoplasms; Lactams, Macrocyclic; Mice; Mice, Nude; Oxides; Reactive Oxygen Species; Transfection

2011